The latest on managing care, value-based care, insurance markets, payers & providers

Social media mesh with dual eligibility

The consulting company PricewaterhouseCoopers, which prefers to call itself PwC now, placed caring for people with dual eligibility among its list of the top 10 health care industry issues in 2013. The people who qualify for both Medicaid and Medicare are considered to be the country’s sickest and poorest people, falling “through the cracks of two programs that were not designed to work together.”

PwC’s study “Top Health Industry Issues of 2013: Picking Up the Pace of Reform” says that $320 billion was spent on dually eligible people in 2011, accounting for 39 percent of total Medicaid and 31 percent of total Medicare spending.

The Centers for Medicare & Medicaid Services hopes that health insurers will help to manage the costs, and social media might be one of the tools. “Some duals may be receptive to using digital communication for diabetes maintenance, weight management, disease management, and chronic care programs,” the study states. PwC finds that such people “are more likely than other consumers to use social media for health care purposes (63 percent compared with 40 percent).”

Interest in using social media

Have you and a doctor, nurse, or other caregiver ever communicated in the following ways about a health question you had?

Dual eligibility

Other consumers




Text messages



Neither of the above



Source: “Top Health Industry Issues of 2013: Picking Up the Pace of Reform,” PricewaterhouseCoopers , January 2013

Subscribe to Our Newsletters

Monthly table of contents

Be notified as each issue of Managed Care is available online.

Biweekly newsletter

Recent topics have included:

  • Doug Jones and the ACA, Epic misses a White House meeting, and man caves for man-flu sufferers
  • CVS-Aetna deal may trigger merger mania, Johns Hopkins criticized for lack of asthma prevention, & Columbia sees free-ride future for all of its med students

PTCommunity news

New drug approvals, clinical trials, drug management. Three times per week.